Diagnoses: a new pathway

Nobody could have predicted the scale and force of Covid-19 but falling diagnosis rates have once again highlighted the need for a more streamlined service. James White argues that people with dementia should be prioritised for pandemic recovery. Every three minutes someone develops dementia in the UK. And yet, many are struggling to access a...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Namaste care on an inpatient assessment ward

Namaste Care reflects a patient-centred philosophy that has begun to prove its worth on hospital wards for people with advanced dementia. Julie Young found that it helped to reduce distress and agitation, reassured families, and strengthened bonds between staff and patients As a concept “Namaste” means to “honour the spirit within” and it has been...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Specialist palliative care for people with dementia

Palliative care towards the end of life is still all too rare for people dying with dementia despite the presence of clear triggers for action. Jennifer Todd and colleagues discuss the findings of their study It is an established principle that people with dementia should have good palliative care, but there remains a failure to...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, Reduced Rate, Member Subscriber - Individual, Member Subscriber - Carer or Person with Dementia , Member Subscriber - Organisation, 1 user, and Member Subscriber - Organisation, 2-10 Users members only.
Login Join Now

Aducanamab: keeping hope informed

A new drug to treat dementia, called aducanumab, has been licensed for use in the USA, but should it be approved in this country too? Toby Williamson warns against placing too much faith in “Big Pharma” and questions the relationship between the business world and dementia care Reports of a new drug that research indicates...

This content is for Individual, Organisation 1 User, Organisation 2-10 Users, Organisation 11-50 Users, Organisation 51+ users, and Reduced Rate members only.
Login Join Now